Gotham Asset Management LLC Purchases 9,132 Shares of Humana Inc. (NYSE:HUM)

Gotham Asset Management LLC boosted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 38.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,593 shares of the insurance provider's stock after buying an additional 9,132 shares during the period. Gotham Asset Management LLC's holdings in Humana were worth $8,269,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. FPC Investment Advisory Inc. bought a new stake in shares of Humana during the fourth quarter valued at approximately $27,000. Centricity Wealth Management LLC acquired a new stake in Humana in the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA boosted its stake in Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after buying an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new stake in Humana in the 4th quarter valued at $33,000. Finally, Transce3nd LLC acquired a new stake in Humana in the 4th quarter valued at $38,000. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

NYSE:HUM traded up $9.95 on Friday, hitting $237.42. The company's stock had a trading volume of 2,548,740 shares, compared to its average volume of 1,767,573. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a fifty day moving average of $263.20 and a two-hundred day moving average of $269.61. The firm has a market capitalization of $28.65 billion, a P/E ratio of 23.86, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. Humana Inc. has a one year low of $212.45 and a one year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The company had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The firm's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $7.23 earnings per share. Research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.49%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 25.04%.

Analysts Set New Price Targets

Several brokerages recently commented on HUM. Truist Financial decreased their price target on Humana from $325.00 to $305.00 and set a "hold" rating on the stock in a research note on Monday. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Barclays boosted their price objective on Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research note on Friday, April 11th. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research note on Thursday, May 1st. Finally, Robert W. Baird boosted their price objective on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Seventeen investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average target price of $286.81.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.